Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of intramuscular versus subcutaneous TBE vaccination routes
2012-001453-74Phase 4Completed
- Sponsor
- Institute of Specific Prophylaxis and Tropical Medicine
- Start
- Apr 2012
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE) (2 arms), sponsored by Institute of Specific Prophylaxis and Tropical Medicine. Primary endpoint: Humoral immunity (primary). Started Apr 2012; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2012-001453-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001453-74.